OOIR: Observatory of International Research

Papers

(The H4-Index of Drug Delivery is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application	185
Milk exosomes-mediated miR-31-5p delivery accelerates diabetic wound healing through promoting angiogenesis	89
Metal nanoparticles as a promising technology in targeted cancer treatment	79
Disitamab vedotin: a novel antibody-drug conjugates for cancer therapy	75
Preservation of small extracellular vesicles for functional analysis and therapeutic applications: a comparative evaluation of storage conditions	74
Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review	63
Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation	63
Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles	61
Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review	57
Exosome-transmitted circVMP1 facilitates the progression and cisplatin resistance of non-small cell lung cancer by targeting miR-524-5p-METTL3/SOX2 axis	57
Progress in the development of stabilization strategies for nanocrystal preparations	56
Preparation and characterization of 2-hydroxyethyl starch microparticles for co-delivery of multiple bioactive agents	54
Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges	53
Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups	52
Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer	50
Recent advances in the local antibiotics delivery systems for management of osteomyelitis	50
Network pharmacology and experimental investigation of Rhizoma polygonati extract targeted kinase with herbzyme activity for potent drug delivery	48
Intra-articular drug delivery systems for osteoarthritis therapy: shifting from sustained release to enhancing penetration into cartilage	46
Functional ligands for improving anticancer drug therapy: current status and applications to drug delivery systems	45
Preparation and use of nanogels as carriers of drugs	45
Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy	44
Hypoxia responsive nano-drug delivery system based on angelica polysaccharide for liver cancer therapy	43
Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p/PTEN/AKT pathway in human liver fibrosis	42
Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy	41
Enrofloxacin/florfenicol loaded cyclodextrin metal-organic-framework for drug delivery and controlled release	40

Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment	37
Structural and biological investigation of chitosan/hyaluronic acid with silanized-hydroxypropyl methylcellulose as an injectable reinforced interpenetrating network hydrogel for cartilage tissue engi	37
Exosome loaded genipin crosslinked hydrogel facilitates full thickness cutaneous wound healing in rat animal model	37
Targeted treatment for osteoarthritis: drugs and delivery system	37
Stimuli-responsive drug delivery systems for head and neck cancer therapy	36
Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery	34
Self-emulsifying drug delivery systems: a novel approach to deliver drugs	34
Layer-by-Layer assembled nano-drug delivery systems for cancer treatment	33